Here's a list of the approved drugs to treat colon cancer, also known as colorectal cancer. Click on any of the medications for more info on indications, dosing and side effects. Keytruda is a PD-1 ...

Combining standard adjuvant chemotherapy with the immune checkpoint inhibitor atezolizumab [Tecentriq] leads to a significant improvement in disease-free survival in a subset of patients with Stage ...

Results from the Phase III SERENA-6 clinical trial found that switching to treatment with camizestrant if an ESR1 mutation is detected during first-line treatment can help slow cancer growth for ...

A pre-surgical combination therapy including pembrolizumab [Keytruda] plus dabrafenib [Tafinlar] and trametinib [Mekinist] (DTP) significantly improved survival in patients with rare BRAF ...

People who used GLP-1 receptor agonists, like Ozempic, had a modestly lower risk for obesity-related malignancies, especially colon and rectal cancer.

The number of people living with a history of cancer in the United States is estimated at 18.6 million as of January 1, 2025 and projected to exceed 22 million by 2035, according to a new report, ...

Welcoming participants to the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place this week Chicago, ASCO CEO Clifford Hudis, MD, acknowledged the detrimental effects of ...

Living with cancer can have detrimental effects on bone health, leading to pain, impaired mobility and increased risk of fractures. But there are ways to prevent and manage bone problems to help ...

Chemotherapy plus immunotherapy maintenance regimen extends progression-free and overall survival for patients with extensive-stage small-cell lung cancer.

Recipients were honored by the National Comprehensive Cancer Network for their passionate efforts to improve lives for people with cancer and their loved ones everywhere.

Researchers use CRISPR-Cas9 gene-editing tool on tumor cells grown in mice to better model how tumors that initially respond to chemotherapy become resistant.

Accurate classification of breast cancer receptor status can help guide treatment decisions, making more patients eligible for HER2 targeted therapies.